{"public_id":"cl_c8b77e3ab4619facd9ffeec5a13d9ee8","status":"active","superseded_by_public_id":null,"corpus_id":205089095,"text":"General health and physical function improved significantly in the normal-range target hemoglobin group, while hypertensive episodes and headaches were more prevalent in that group despite no significant difference in combined adverse events.","confidence":0.94,"paper":{"corpus_id":205089095,"title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia.","url":"https://sah.borca.ai/papers/205089095"},"contributors":[{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["extraction"],"url":"https://sah.borca.ai/u/b2adb6bfad"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.94,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0fb666f2790ce767cb049f78de4f6438","name":"headaches","description":"Symptom adverse events compared between the treatment groups.","types":["adverse event"],"url":"https://sah.borca.ai/concepts/co_0fb666f2790ce767cb049f78de4f6438"},{"public_id":"co_23a5c64c7b58ba47a14ae7c29125d867","name":"hypertensive episodes","description":"Blood-pressure-related adverse events compared between the treatment groups.","types":["adverse event"],"url":"https://sah.borca.ai/concepts/co_23a5c64c7b58ba47a14ae7c29125d867"},{"public_id":"co_a84f69d5a2170c7edf4d803e8af02262","name":"general health and physical function","description":"Quality-of-life domains evaluated as secondary endpoints in the trial.","types":["quality-of-life outcome"],"url":"https://sah.borca.ai/concepts/co_a84f69d5a2170c7edf4d803e8af02262"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_c8b77e3ab4619facd9ffeec5a13d9ee8"}